Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay
Recall Z-1171-2016, part of FDA recall event 73129. See Sekisui Diagnostics P.E.I.'s company page.
Sekisui Diagnostics P.E.I. Inc. started this Class II device recall on Jan 22, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Aug 9, 2016.
- Classification: Class II
- Started: Jan 22, 2016
- Status: Terminated
Crystal formation in the Color Reagent (R2) when left on board automated analyzers causing samples to under recover
- Product
- Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay, In-vitro Diagnostic Catalog Number: 506-10: R1: 1 x 10ml, R2: 2 x 10ml Catalog Number: 506-30: R1: 3 x 10ml, R2: 6 x 10ml In-Vitro quantitative measurement of Acetaminophen in serum and plasma used m the diagnosis and treatment of acetaminophen overdose toxicity.
- Quantity
- 14,407 kits.
- Lots and codes
- Catalog Number: 506-10 Lot Codes 47677 47694 47649 47650 47662 47663 48253 48385 48386 Catalog Number: 506-30 Lot Codes: 47695 48294
- Distribution
- Worldwide Distribution - US Distribution to the states of : AZ, CA, FL, IA, ID, IL, MA, , MN, MT and ND., and to the countries of Canada, France and Hong Kong.
- Recalling firm
- Sekisui Diagnostics P.E.I. Inc., Charlottetown, Canada
- How the firm notified
- Letter
- FDA classified
- Mar 14, 2016
Newest first, one product per recall event; search them all
- Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement…Z-1078-2017 · Class II · Nov 29, 2016 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports